FindTrial
Sign In

Effect of Dietary Magnesium on Control of Blood Pressure in Hypertensives.

Can Subclinical Magnesium Deficiency be Attributed a Role in Poor Control of Hypertension? A 24-hour Urine Analysis Study Assessing Magnesium Status of Hypertensives on Treatment.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/04/018727
Enrollment
80
Registered
2019-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

GMERS Medical College and General Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Essential Hypertension patients, reporting for follow up, who were on standard anti-hypertensive medication as per JNC 8 guidelines.

Exclusion criteria

Exclusion criteria: Patients on Diuretics, Proton pump inhibitors or any other medication altering magnesium metabolism. Patients with Chronic Kidney disease, Critically ill and morbidly obese patients.

Design outcomes

Primary

MeasureTime frame
24-hour urinary Magnesium level in hypertensive patients and its correlation with blood pressure control Timepoint: 4 days—

Secondary

MeasureTime frame
Serum Magnesium level in hypertensive patients and its correlation with blood pressure controlTimepoint: 2 days—

Countries

India

Contacts

Public ContactVidhi K Patel

GMERS Medical College, Gotri, Vadodara

dr.ashutoshchauhan@gmail.com9638771569

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026